Evidence map›Paper›PMID 36799012›Full record

ArticleEpidemiology and infection2023

Characteristics of patients with SARS-COV-2 PCR re-positivity after recovering from COVID-19.

Cheng-Yi Hu, Yi Lei, Yu-Wen Tang, Wen-Shuai Cui, Pei-Lian Wu, Yan-Fang Li, Yan Zhou, Xin-Yan Li, Hao Cui, Lu-Shan Xiao and 1 more

Full text read
PubMed Full text at PMC Publisher
In one paragraph

Article in Epidemiology and infection, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Cheng-Yi HuDepartment of Infectious Diseases, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, Guangdong, China.
Yi LeiDepartment of Infectious Diseases, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, Guangdong, China.
Yu-Wen TangDepartment of Infectious Diseases, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, Guangdong, China.
Wen-Shuai CuiDepartment of Infectious Diseases, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, Guangdong, China.
Pei-Lian WuDepartment of Respiratory Disease, Eighth People's Hospital of Guangzhou, Guangzhou Medical University, Guangzhou, China.
Yan-Fang LiDepartment of Infectious Diseases, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, Guangdong, China.
Yan ZhouDepartment of Infectious Diseases, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, Guangdong, China.
Xin-Yan LiDepartment of Infectious Diseases, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, Guangdong, China.
Hao CuiDepartment of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Lu-Shan XiaoDepartment of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Zhu-Xiang ZhaoDepartment of Infectious Diseases, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, Guangdong, China.ORCID 0000-0003-3638-298X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The purpose of this study was to analyse the clinical characteristics of patients with severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) PCR re-positivity after recovering from coronavirus disease 2019 (COVID-19). Patients (

Indexed as

COVID-19COVID-19 TestingCOVID-19 VaccinesHumansPolymerase Chain ReactionSARS-CoV-2COVID-19 VaccinesClinical characteristicsCOVID-19predictive modelrepeat test positivitySARS-CoV-2 infection

Identifiers

PMID36799012
PMCPMC10019929

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read174
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.